{
 "awd_id": "0318840",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "SBIR Phase I: Regulated Expression of Therapeutic Proteins in Transgenic Brassica Plants",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Om P. Sahai",
 "awd_eff_date": "2003-07-01",
 "awd_exp_date": "2004-04-30",
 "tot_intn_awd_amt": 95846.0,
 "awd_amount": 95846.0,
 "awd_min_amd_letter_date": "2003-06-24",
 "awd_max_amd_letter_date": "2004-01-13",
 "awd_abstract_narration": "This Small Business Innovation Research (SBIR) Phase I project proposes to evaluate the use of Brassica juncea as a low cost source of human therapeutic proteins. The proposed research would utilize a newly developed floral transformation method to introduce the gene encoding human alpha-interferon, together with a regulated plant promoter and an optimized translation initiation sequence for high level expression in Brassica juncea. Floral transformation produces large numbers (25%) of transgenic Brassica seedlings within 3 weeks. Transformed plants will be selected by herbicide resistance and expression of interferon after induction of the promoter measured by immunoblotting. The anticipated outcome of this project will be a well regulated, high level expression system for a rapidly growing, inexpensive, hydroponically cultivated crop plant as a source of therapeutically valuable proteins.\r\n\r\nThe commercial application of this project will be the low cost manufacture of  human therapeutics using plant biotechnology.\r\n",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Burt",
   "pi_last_name": "Ensley",
   "pi_mid_init": "D",
   "pi_sufx_name": "",
   "pi_full_name": "Burt D Ensley",
   "pi_email_addr": "burtensley@aol.com",
   "nsf_id": "000132352",
   "pi_start_date": "2003-06-24",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "NuCycle Therapy, Inc.",
  "inst_street_address": "225 Long Avenue",
  "inst_street_address_2": "",
  "inst_city_name": "Hillside",
  "inst_state_code": "NJ",
  "inst_state_name": "New Jersey",
  "inst_phone_num": "9282034127",
  "inst_zip_code": "072050205",
  "inst_country_name": "United States",
  "cong_dist_code": "10",
  "st_cong_dist_code": "NJ10",
  "org_lgl_bus_name": null,
  "org_prnt_uei_num": null,
  "org_uei_num": null
 },
 "perf_inst": {
  "perf_inst_name": "NuCycle Therapy, Inc.",
  "perf_str_addr": "225 Long Avenue",
  "perf_city_name": "Hillside",
  "perf_st_code": "NJ",
  "perf_st_name": "New Jersey",
  "perf_zip_code": "072050205",
  "perf_ctry_code": "US",
  "perf_cong_dist": "10",
  "perf_st_cong_dist": "NJ10",
  "perf_ctry_name": "",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537100",
   "pgm_ele_name": "SBIR Phase I"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "9109",
   "pgm_ref_txt": "AGRICULTURAL BIOTECHNOLOGY"
  },
  {
   "pgm_ref_code": "BIOT",
   "pgm_ref_txt": "BIOTECHNOLOGY"
  }
 ],
 "app_fund": [
  {
   "app_code": "0103",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0103",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 2003,
   "fund_oblg_amt": 95846.0
  }
 ],
 "por": null
}